Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients

Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients

ContextThe management of behavioral symptoms and rigidity in patients with dementia constitutes a significant challenge. Short-term studies suggest an interest in the use of medical cannabis, but long-term data are lacking.ObjectivesThe objective of this study was to investigate the feasibility and...

Full description

Bibliographic Details
Main Authors: Sophie Pautex, Federica Bianchi, Youssef Daali, Marc Augsburger, Christian de Saussure, James Wampfler, François Curtin, Jules Desmeules, Barbara Broers
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Aging Neuroscience
Subjects:
cannabinoids
dementia
symptoms relief
long-term care
medical cannabis
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2022.957665/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2022.957665/full

Similar Items